Cramer's Watch List Ahead of Big Cancer Conference
May 20, 2013
The American Society of Clinical Oncology meeting scheduled to begin on May 31st could generate a cornucopia of health care catalysts, said Jim Cramer. Read More
from CNBC.com News
Griffin's Blue Ridge Capital Enters CBS (CBS), Citigroup (C), Netflix (NFLX); Exits Apple (AAPL)
May 15, 2013
Today’s Research on DCTH, AKRX, ASTX, BMRN, and FRX
May 10, 2013
from ACCESSWIRE
BioMarin Pharmaceuticals, Inc. (BMRN) Misses Q1 EPS by 2c
April 25, 2013
Trading Radar for 04/25: Exxon, (XOM), Dow (DOW), 3M (MMM), Hershey (HSY), UPS (UPS), Expedia (EXPE) Report
April 24, 2013
The Coming Boom in Healthcare M&A
April 22, 2013
BioMarin Pharmaceutical Inc. Moves Up In Market Cap Rank, Passing Juniper Networks Inc
April 19, 2013
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component BioMarin Pharmaceutical Inc. (BMRN) was identified as having a larger market cap than the smaller end of... Read More
category
Stocks
from Market News Video
BioMarin Pharmaceutical Crosses Below its 10-day MA (BMRN)
April 18, 2013
Short Interest Moves 62% Lower For BMRN
April 10, 2013
The most recent short interest data has been released by the NASDAQ for the 03/28/2013 settlement date, which shows a 7,437,778 share decrease in total short interest for BioMarin Pharmaceutical Inc.... Read More
category
Stocks
from Market News Video
Cramer: Small Drug Stocks with Promising Pipelines
April 01, 2013
If you're looking for a small stock with big return potential, Jim Cramer thinks you should consider this. Read More
from CNBC.com News
BioMarin Pharmaceutical: The Winning Streak Continues (BMRN)
April 01, 2013
BioMarin (BMRN) Submits CTA for BMN-190 to U.K.'s MHRA
April 01, 2013
BioMarin (BMRN) Submits BLA for Vimizim to FDA
April 01, 2013
Get out of junk stocks now
March 22, 2013
Because the Federal Reserve’s easy-money policies won’t continue indefinitely, investors might want to begin reducing their holdings of low-quality stocks — which will be among the biggest casualties... Read More
from MarketWatch
BioMarin to Advance BMN-701 for Pompe Disease to Next Phase of Trials, Sees Phase 2/3 Switching Trial by End of 2013
March 19, 2013
BioMarin Pharmaceutical Crosses Above its 10-day MA (BMRN)
March 18, 2013
Cramer: 8 Top Performers Over Last 8 Years
March 15, 2013
Who says you can't beat the market. Had you picked stocks thoughtfully and carefully, since Mad Money began, you could have beaten the S&P by 3000%! Read More
category
Regeneron Pharmaceuticals Inc
,
CRM Holdings Ltd/
,
BioMarin Pharmaceutical Inc
, and 23 more.
from CNBC.com News
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here